On June 30, 2026, Halozyme Therapeutics announced an update to its senior management structure and the departure of Cortney Caudill from her role as Senior Vice President and Chief Operating Officer. The company operates in the biotechnology industry and develops subcutaneous delivery technologies for pharmaceutical drugs.
